CASTLE (Clopidogrel And Serum Troponin Level Elevation)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Primary Objective: To test if 600 mg of clopidogrel loading dose administered ≥ 6 and ≤ 24
hours prior to PCI produce a greater decrease of periprocedural release of biochemical
markers (CK, CK-MB, and troponin-T and/or I) of myocardial necrosis, compared to 300 mg
loading dose, given ≥ 6 and ≤ 24 hours prior to PCI or 600 mg loading dose of clopidogrel,
administered immediately (≤ 45 minutes) before PCI.